Novo Nordisk Continues Fight Against Diabetes
A faster-acting mealtime insulin manufactured by Novo Nordisk is now approved and available in Canada. Novo Nordisk Canada Inc. announced that Fiasp (insulin aspart), a faster-acting mealtime insulin, is now approved and available in Canada. Fiasp is an innovative formulation of insulin aspart that more closely matches the natural physiological insulin response of a person without [...]